+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Cough Suppressant Drugs Market Research Report by Drug Type, by Dosage Form, by Disease Type, by Distribution Channel, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19

  • ID: 4989771
  • Report
  • July 2021
  • Region: Global
  • 187 pages
  • 360iResearch™
UP TO OFF
until Sep 30th 2021
The Global Cough Suppressant Drugs Market will Grow to USD 2,267.42 Million by 2026, at a CAGR of 4.44%

FEATURED COMPANIES

  • Aurobindo Pharma Limited
  • Aytu BioScience, Inc.
  • GlaxoSmithKline plc
  • Mayne Pharma, Inc.
  • Pfizer Inc.
  • Tris Pharma, Inc.
  • MORE
The Global Cough Suppressant Drugs Market size was estimated at USD 1,746.91 Million in 2020 and expected to reach USD 1,818.60 Million in 2021, at a Compound Annual Growth Rate (CAGR) 4.44% to reach USD 2,267.42 Million by 2026.



Market Statistics:


The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2026 are considered the forecast period.

Market Segmentation & Coverage:


This research report categorizes the Cough Suppressant Drugs to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Drug Type, the Cough Suppressant Drugs Market was studied across Benzonatate, Butamirate, Codeine, Dextromethorphan, Noscapine, and Pholcodine.
  • Based on Age Group, the Cough Suppressant Drugs Market was studied across Adult and Pediatric.
  • Based on Dosage Form, the Cough Suppressant Drugs Market was studied across Syrup and Tablet.
  • Based on Disease Type, the Cough Suppressant Drugs Market was studied across Dry Cough and Wet Cough.
  • Based on Distribution Channel, the Cough Suppressant Drugs Market was studied across Hospital, Online Pharmacy, and Retail Drug Store.
  • Based on Region, the Cough Suppressant Drugs Market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:


COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Competitive Strategic Window:


The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:


The FPNV Positioning Matrix evaluates and categorizes the vendors in the Cough Suppressant Drugs Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:


The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Company Usability Profiles:


The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Cough Suppressant Drugs Market, including Acella Pharmaceuticals, LLC, Amneal Pharmaceuticals, Inc., Aurobindo Pharma Limited, Aytu BioScience, Inc., GlaxoSmithKline plc, Mayne Pharma, Inc., Pfizer Inc., Taro Pharmaceutical Industries, Tris Pharma, Inc., and Vernalis plc.

The report provides insights on the following pointers:


1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:


1. What is the market size and forecast of the Global Cough Suppressant Drugs Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Cough Suppressant Drugs Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Cough Suppressant Drugs Market?
4. What is the competitive strategic window for opportunities in the Global Cough Suppressant Drugs Market?
5. What are the technology trends and regulatory frameworks in the Global Cough Suppressant Drugs Market?
6. What is the market share of the leading vendors in the Global Cough Suppressant Drugs Market?
7. What modes and strategic moves are considered suitable for entering the Global Cough Suppressant Drugs Market?
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Aurobindo Pharma Limited
  • Aytu BioScience, Inc.
  • GlaxoSmithKline plc
  • Mayne Pharma, Inc.
  • Pfizer Inc.
  • Tris Pharma, Inc.
  • MORE
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary
3.1. Introduction
3.2. Market Outlook
3.3. Drug Type Outlook
3.4. Age Group Outlook
3.5. Dosage Form Outlook
3.6. Disease Type Outlook
3.7. Distribution Channel Outlook
3.8. Region Outlook
3.9. Competitor Outlook

4. Market Overview
4.1. Introduction
4.2. Cumulative Impact of COVID-19

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increase in the cases of chronic cough
5.1.1.2. Growing demand for cough suppressant drugs by the consumers
5.1.1.3. Surge in demand from the medical industry
5.1.2. Restraints
5.1.2.1. Side effects associated with the use of cough suppressant drugs
5.1.3. Opportunities
5.1.3.1. Rise in the number of product launches
5.1.3.2. Ongoing research activities in the healthcare sector
5.1.4. Challenges
5.1.4.1. Huge cost associated with treatment and shortage of skilled labor
5.2. Porters Five Forces Analysis
5.2.1. Threat of New Entrants
5.2.2. Threat of Substitutes
5.2.3. Bargaining Power of Customers
5.2.4. Bargaining Power of Suppliers
5.2.5. Industry Rivalry

6. Cough Suppressant Drugs Market, by Drug Type
6.1. Introduction
6.2. Benzonatate
6.3. Butamirate
6.4. Codeine
6.5. Dextromethorphan
6.6. Noscapine
6.7. Pholcodine

7. Cough Suppressant Drugs Market, by Age Group
7.1. Introduction
7.2. Adult
7.3. Pediatric

8. Cough Suppressant Drugs Market, by Dosage Form
8.1. Introduction
8.2. Syrup
8.3. Tablet

9. Cough Suppressant Drugs Market, by Disease Type
9.1. Introduction
9.2. Dry Cough
9.3. Wet Cough

10. Cough Suppressant Drugs Market, by Distribution Channel
10.1. Introduction
10.2. Hospital
10.3. Online Pharmacy
10.4. Retail Drug Store

11. Americas Cough Suppressant Drugs Market
11.1. Introduction
11.2. Argentina
11.3. Brazil
11.4. Canada
11.5. Mexico
11.6. United States

12. Asia-Pacific Cough Suppressant Drugs Market
12.1. Introduction
12.2. Australia
12.3. China
12.4. India
12.5. Indonesia
12.6. Japan
12.7. Malaysia
12.8. Philippines
12.9. Singapore
12.10. South Korea
12.11. Thailand

13. Europe, Middle East & Africa Cough Suppressant Drugs Market
13.1. Introduction
13.2. France
13.3. Germany
13.4. Italy
13.5. Netherlands
13.6. Qatar
13.7. Russia
13.8. Saudi Arabia
13.9. South Africa
13.10. Spain
13.11. United Arab Emirates
13.12. United Kingdom

14. Competitive Landscape
14.1. FPNV Positioning Matrix
14.1.1. Quadrants
14.1.2. Business Strategy
14.1.3. Product Satisfaction
14.2. Market Ranking Analysis
14.3. Market Share Analysis, By Key Player
14.4. Competitive Scenario
14.4.1. Merger & Acquisition
14.4.2. Agreement, Collaboration, & Partnership
14.4.3. New Product Launch & Enhancement
14.4.4. Investment & Funding
14.4.5. Award, Recognition, & Expansion

15. Company Usability Profiles
15.1. Acella Pharmaceuticals, LLC
15.2. Amneal Pharmaceuticals, Inc.
15.3. Aurobindo Pharma Limited
15.4. Aytu BioScience, Inc.
15.5. GlaxoSmithKline plc
15.6. Mayne Pharma, Inc.
15.7. Pfizer Inc.
15.8. Taro Pharmaceutical Industries
15.9. Tris Pharma, Inc.
15.10. Vernalis plc

16. Appendix
16.1. Discussion Guide
16.2. License & Pricing

List of Figures
FIGURE 1. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, 2020 VS 2026 (USD MILLION)
FIGURE 2. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DRUG TYPE, 2020 (USD MILLION)
FIGURE 3. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY AGE GROUP, 2020 (USD MILLION)
FIGURE 4. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DOSAGE FORM, 2020 (USD MILLION)
FIGURE 5. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISEASE TYPE, 2020 (USD MILLION)
FIGURE 6. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2020 (USD MILLION)
FIGURE 7. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY REGION, 2020 (USD MILLION)
FIGURE 8. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 9. GLOBAL COUGH SUPPRESSANT DRUGS MARKET: MARKET DYNAMICS
FIGURE 10. GLOBAL COUGH SUPPRESSANT DRUGS MARKET: PORTERS FIVE FORCES ANALYSIS
FIGURE 11. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DRUG TYPE, 2020 VS 2026 (%)
FIGURE 12. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DRUG TYPE, 2020 VS 2026 (USD MILLION)
FIGURE 13. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DRUG TYPE, 2026
FIGURE 14. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY BENZONATATE, 2018-2026 (USD MILLION)
FIGURE 15. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY BENZONATATE, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 16. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY BUTAMIRATE, 2018-2026 (USD MILLION)
FIGURE 17. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY BUTAMIRATE, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 18. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY CODEINE, 2018-2026 (USD MILLION)
FIGURE 19. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY CODEINE, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 20. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DEXTROMETHORPHAN, 2018-2026 (USD MILLION)
FIGURE 21. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DEXTROMETHORPHAN, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 22. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY NOSCAPINE, 2018-2026 (USD MILLION)
FIGURE 23. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY NOSCAPINE, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 24. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY PHOLCODINE, 2018-2026 (USD MILLION)
FIGURE 25. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY PHOLCODINE, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 26. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY AGE GROUP, 2020 VS 2026 (%)
FIGURE 27. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY AGE GROUP, 2020 VS 2026 (USD MILLION)
FIGURE 28. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY AGE GROUP, 2026
FIGURE 29. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY ADULT, 2018-2026 (USD MILLION)
FIGURE 30. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY ADULT, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 31. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY PEDIATRIC, 2018-2026 (USD MILLION)
FIGURE 32. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY PEDIATRIC, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 33. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DOSAGE FORM, 2020 VS 2026 (%)
FIGURE 34. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DOSAGE FORM, 2020 VS 2026 (USD MILLION)
FIGURE 35. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DOSAGE FORM, 2026
FIGURE 36. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY SYRUP, 2018-2026 (USD MILLION)
FIGURE 37. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY SYRUP, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 38. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY TABLET, 2018-2026 (USD MILLION)
FIGURE 39. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY TABLET, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 40. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISEASE TYPE, 2020 VS 2026 (%)
FIGURE 41. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISEASE TYPE, 2020 VS 2026 (USD MILLION)
FIGURE 42. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISEASE TYPE, 2026
FIGURE 43. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DRY COUGH, 2018-2026 (USD MILLION)
FIGURE 44. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DRY COUGH, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 45. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY WET COUGH, 2018-2026 (USD MILLION)
FIGURE 46. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY WET COUGH, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 47. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2020 VS 2026 (%)
FIGURE 48. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2020 VS 2026 (USD MILLION)
FIGURE 49. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2026
FIGURE 50. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY HOSPITAL, 2018-2026 (USD MILLION)
FIGURE 51. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY HOSPITAL, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 52. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY ONLINE PHARMACY, 2018-2026 (USD MILLION)
FIGURE 53. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 54. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY RETAIL DRUG STORE, 2018-2026 (USD MILLION)
FIGURE 55. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY RETAIL DRUG STORE, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 56. AMERICAS COUGH SUPPRESSANT DRUGS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 57. ARGENTINA COUGH SUPPRESSANT DRUGS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 58. BRAZIL COUGH SUPPRESSANT DRUGS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 59. CANADA COUGH SUPPRESSANT DRUGS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 60. MEXICO COUGH SUPPRESSANT DRUGS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 61. UNITED STATES COUGH SUPPRESSANT DRUGS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 62. ASIA-PACIFIC COUGH SUPPRESSANT DRUGS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 63. AUSTRALIA COUGH SUPPRESSANT DRUGS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 64. CHINA COUGH SUPPRESSANT DRUGS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 65. INDIA COUGH SUPPRESSANT DRUGS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 66. INDONESIA COUGH SUPPRESSANT DRUGS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 67. JAPAN COUGH SUPPRESSANT DRUGS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 68. MALAYSIA COUGH SUPPRESSANT DRUGS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 69. PHILIPPINES COUGH SUPPRESSANT DRUGS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 70. SINGAPORE COUGH SUPPRESSANT DRUGS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 71. SOUTH KOREA COUGH SUPPRESSANT DRUGS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 72. THAILAND COUGH SUPPRESSANT DRUGS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 73. EUROPE, MIDDLE EAST & AFRICA COUGH SUPPRESSANT DRUGS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 74. FRANCE COUGH SUPPRESSANT DRUGS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 75. GERMANY COUGH SUPPRESSANT DRUGS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 76. ITALY COUGH SUPPRESSANT DRUGS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 77. NETHERLANDS COUGH SUPPRESSANT DRUGS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 78. QATAR COUGH SUPPRESSANT DRUGS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 79. RUSSIA COUGH SUPPRESSANT DRUGS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 80. SAUDI ARABIA COUGH SUPPRESSANT DRUGS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 81. SOUTH AFRICA COUGH SUPPRESSANT DRUGS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 82. SPAIN COUGH SUPPRESSANT DRUGS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 83. UNITED ARAB EMIRATES COUGH SUPPRESSANT DRUGS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 84. UNITED KINGDOM COUGH SUPPRESSANT DRUGS MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 85. GLOBAL COUGH SUPPRESSANT DRUGS MARKET: FPNV POSITIONING MATRIX
FIGURE 86. GLOBAL COUGH SUPPRESSANT DRUGS MARKET: SHARE, BY KEY PLAYER, 2020
FIGURE 87. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL COUGH SUPPRESSANT DRUGS MARKET, BY TYPE

List of Tables
TABLE 1. GLOBAL COUGH SUPPRESSANT DRUGS MARKET: MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016–2020
TABLE 3. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 4. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2026 (USD MILLION)
TABLE 5. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY BENZONATATE, BY REGION, 2018-2026 (USD MILLION)
TABLE 6. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY BUTAMIRATE, BY REGION, 2018-2026 (USD MILLION)
TABLE 7. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY CODEINE, BY REGION, 2018-2026 (USD MILLION)
TABLE 8. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DEXTROMETHORPHAN, BY REGION, 2018-2026 (USD MILLION)
TABLE 9. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY NOSCAPINE, BY REGION, 2018-2026 (USD MILLION)
TABLE 10. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY PHOLCODINE, BY REGION, 2018-2026 (USD MILLION)
TABLE 11. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY AGE GROUP, 2018-2026 (USD MILLION)
TABLE 12. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY ADULT, BY REGION, 2018-2026 (USD MILLION)
TABLE 13. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2026 (USD MILLION)
TABLE 14. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2026 (USD MILLION)
TABLE 15. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY SYRUP, BY REGION, 2018-2026 (USD MILLION)
TABLE 16. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY TABLET, BY REGION, 2018-2026 (USD MILLION)
TABLE 17. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISEASE TYPE, 2018-2026 (USD MILLION)
TABLE 18. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DRY COUGH, BY REGION, 2018-2026 (USD MILLION)
TABLE 19. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY WET COUGH, BY REGION, 2018-2026 (USD MILLION)
TABLE 20. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD MILLION)
TABLE 21. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2026 (USD MILLION)
TABLE 22. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2026 (USD MILLION)
TABLE 23. GLOBAL COUGH SUPPRESSANT DRUGS MARKET SIZE, BY RETAIL DRUG STORE, BY REGION, 2018-2026 (USD MILLION)
TABLE 24. AMERICAS COUGH SUPPRESSANT DRUGS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 25. ARGENTINA COUGH SUPPRESSANT DRUGS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 26. BRAZIL COUGH SUPPRESSANT DRUGS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 27. CANADA COUGH SUPPRESSANT DRUGS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 28. MEXICO COUGH SUPPRESSANT DRUGS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 29. UNITED STATES COUGH SUPPRESSANT DRUGS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 30. ASIA-PACIFIC COUGH SUPPRESSANT DRUGS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 31. AUSTRALIA COUGH SUPPRESSANT DRUGS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 32. CHINA COUGH SUPPRESSANT DRUGS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 33. INDIA COUGH SUPPRESSANT DRUGS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 34. INDONESIA COUGH SUPPRESSANT DRUGS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 35. JAPAN COUGH SUPPRESSANT DRUGS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 36. MALAYSIA COUGH SUPPRESSANT DRUGS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 37. PHILIPPINES COUGH SUPPRESSANT DRUGS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 38. SINGAPORE COUGH SUPPRESSANT DRUGS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 39. SOUTH KOREA COUGH SUPPRESSANT DRUGS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 40. THAILAND COUGH SUPPRESSANT DRUGS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 41. EUROPE, MIDDLE EAST & AFRICA COUGH SUPPRESSANT DRUGS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 42. FRANCE COUGH SUPPRESSANT DRUGS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 43. GERMANY COUGH SUPPRESSANT DRUGS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 44. ITALY COUGH SUPPRESSANT DRUGS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 45. NETHERLANDS COUGH SUPPRESSANT DRUGS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 46. QATAR COUGH SUPPRESSANT DRUGS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 47. RUSSIA COUGH SUPPRESSANT DRUGS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 48. SAUDI ARABIA COUGH SUPPRESSANT DRUGS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 49. SOUTH AFRICA COUGH SUPPRESSANT DRUGS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 50. SPAIN COUGH SUPPRESSANT DRUGS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 51. UNITED ARAB EMIRATES COUGH SUPPRESSANT DRUGS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 52. UNITED KINGDOM COUGH SUPPRESSANT DRUGS MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 53. GLOBAL COUGH SUPPRESSANT DRUGS MARKET: SCORES
TABLE 54. GLOBAL COUGH SUPPRESSANT DRUGS MARKET: BUSINESS STRATEGY
TABLE 55. GLOBAL COUGH SUPPRESSANT DRUGS MARKET: PRODUCT SATISFACTION
TABLE 56. GLOBAL COUGH SUPPRESSANT DRUGS MARKET: RANKING
TABLE 57. GLOBAL COUGH SUPPRESSANT DRUGS MARKET: SHARE, BY KEY PLAYER, 2020
TABLE 58. GLOBAL COUGH SUPPRESSANT DRUGS MARKET: MERGER & ACQUISITION
TABLE 59. GLOBAL COUGH SUPPRESSANT DRUGS MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 60. GLOBAL COUGH SUPPRESSANT DRUGS MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 61. GLOBAL COUGH SUPPRESSANT DRUGS MARKET: INVESTMENT & FUNDING
TABLE 62. GLOBAL COUGH SUPPRESSANT DRUGS MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 63. GLOBAL COUGH SUPPRESSANT DRUGS MARKET: LICENSE & PRICING
Note: Product cover images may vary from those shown
  • Acella Pharmaceuticals, LLC
  • Amneal Pharmaceuticals, Inc.
  • Aurobindo Pharma Limited
  • Aytu BioScience, Inc.
  • GlaxoSmithKline plc
  • Mayne Pharma, Inc.
  • Pfizer Inc.
  • Taro Pharmaceutical Industries
  • Tris Pharma, Inc.
  • Vernalis plc
Note: Product cover images may vary from those shown

Loading
LOADING...

Adroll
adroll